BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yue X, Rao A. TET family dioxygenases and the TET activator vitamin C in immune responses and cancer. Blood 2020;136:1394-401. [PMID: 32730592 DOI: 10.1182/blood.2019004158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Alagia A, Gullerova M. The Methylation Game: Epigenetic and Epitranscriptomic Dynamics of 5-Methylcytosine. Front Cell Dev Biol 2022;10:915685. [DOI: 10.3389/fcell.2022.915685] [Reference Citation Analysis]
2 Dvoriantchikova G, Lypka KR, Ivanov D. The Potential Role of Epigenetic Mechanisms in the Development of Retinitis Pigmentosa and Related Photoreceptor Dystrophies. Front Genet 2022;13:827274. [DOI: 10.3389/fgene.2022.827274] [Reference Citation Analysis]
3 Ostriker AC, Xie Y, Chakraborty R, Sizer AJ, Bai Y, Ding M, Song WL, Huttner A, Hwa J, Martin KA. TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy. Circulation 2021;144:455-70. [PMID: 34111946 DOI: 10.1161/CIRCULATIONAHA.120.050553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chen HY, Hsu M, Lio CJ. Micro but mighty-Micronutrients in the epigenetic regulation of adaptive immune responses. Immunol Rev 2021. [PMID: 34820863 DOI: 10.1111/imr.13045] [Reference Citation Analysis]
5 Meacham CE, DeVilbiss AW, Morrison SJ. Metabolic regulation of somatic stem cells in vivo. Nat Rev Mol Cell Biol 2022. [PMID: 35228719 DOI: 10.1038/s41580-022-00462-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Srivastava R, Lodhi N. DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1. Biomolecules 2022;12:417. [DOI: 10.3390/biom12030417] [Reference Citation Analysis]
7 Yue X, Samaniego-Castruita D, González-Avalos E, Li X, Barwick BG, Rao A. Whole-genome analysis of TET dioxygenase function in regulatory T cells. EMBO Rep 2021;22:e52716. [PMID: 34288360 DOI: 10.15252/embr.202152716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Laurent A, Madigou T, Bizot M, Turpin M, Palierne G, Mahé E, Guimard S, Métivier R, Avner S, Le Péron C, Salbert G. TET2-mediated epigenetic reprogramming of breast cancer cells impairs lysosome biogenesis. Life Sci Alliance 2022;5:e202101283. [DOI: 10.26508/lsa.202101283] [Reference Citation Analysis]
9 Zhao S, Allis CD, Wang GG. The language of chromatin modification in human cancers. Nat Rev Cancer 2021;21:413-30. [PMID: 34002060 DOI: 10.1038/s41568-021-00357-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Hammond D, Loghavi S. Clonal haematopoiesis of emerging significance. Pathology 2021;53:300-11. [PMID: 33685721 DOI: 10.1016/j.pathol.2021.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Niessner H, Burkard M, Leischner C, Renner O, Plöger S, Meraz-Torres F, Böcker M, Hirn C, Lauer UM, Venturelli S, Busch C, Sinnberg T. Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells 2022;11:1229. [PMID: 35406796 DOI: 10.3390/cells11071229] [Reference Citation Analysis]
12 Tsagaratou A. Deciphering the multifaceted roles of TET proteins in T-cell lineage specification and malignant transformation. Immunol Rev 2021;300:22-36. [PMID: 33410200 DOI: 10.1111/imr.12940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Brabson JP, Leesang T, Mohammad S, Cimmino L. Epigenetic Regulation of Genomic Stability by Vitamin C. Front Genet 2021;12:675780. [PMID: 34017357 DOI: 10.3389/fgene.2021.675780] [Reference Citation Analysis]
14 Link CN, Thalalla Gamage S, Gallimore D, Kopajtich R, Evans C, Nance S, Fox SD, Andresson T, Chari R, Ivanic J, Prokisch H, Meier JL. Protonation-Dependent Sequencing of 5-Formylcytidine in RNA. Biochemistry 2022. [PMID: 35285626 DOI: 10.1021/acs.biochem.1c00761] [Reference Citation Analysis]
15 Testa U, Pelosi E, Castelli G. New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug. Hematol Oncol Stem Cell Ther 2021;14:179-91. [PMID: 33278349 DOI: 10.1016/j.hemonc.2020.11.002] [Reference Citation Analysis]
16 Wan F, Chen F, Fan Y, Chen D. Clinical Significance of TET2 in Female Cancers. Front Bioeng Biotechnol 2022;10:790605. [DOI: 10.3389/fbioe.2022.790605] [Reference Citation Analysis]
17 Chakraborty R, Chatterjee P, Dave JM, Ostriker AC, Greif DM, Rzucidlo EM, Martin KA. Targeting smooth muscle cell phenotypic switching in vascular disease. JVS Vasc Sci 2021;2:79-94. [PMID: 34617061 DOI: 10.1016/j.jvssci.2021.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tsiouplis NJ, Bailey DW, Chiou LF, Wissink FJ, Tsagaratou A. TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease. Front Cell Dev Biol 2020;8:623948. [PMID: 33520997 DOI: 10.3389/fcell.2020.623948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res 2021;40:343. [PMID: 34717701 DOI: 10.1186/s13046-021-02134-y] [Reference Citation Analysis]